We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock

Delisted

TPTX was delisted on the 16th of August, 2022.

166 hedge funds and large institutions have $3.45B invested in Turning Point Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 79 increasing their positions, 44 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

80% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 44

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

44% more capital invested

Capital invested by funds: $2.4B → $3.45B (+$1.05B)

5% more funds holding

Funds holding: 158166 (+8)

1% less call options, than puts

Call options by funds: $1.75M | Put options by funds: $1.77M

Holders
166
Holders Change
+8
Holders Change %
+5.06%
% of All Funds
3.35%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.1%
New
23
Increased
79
Reduced
44
Closed
15
Calls
$1.75M
Puts
$1.77M
Net Calls
-$25K
Net Calls Change
-$25K
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
51
Fred Alger Management
New York
$8.07M +$960K +13,788 +18%
Axa
52
Axa
France
$7.99M -$2.8M -40,151 -31%
SCM
53
Suvretta Capital Management
New York
$6.93M +$3.77M +54,100 +214%
BCM
54
Burrage Capital Management
Massachusetts
$6.82M +$65.9K +946 +1%
Swiss National Bank
55
Swiss National Bank
Switzerland
$6.67M +$188K +2,700 +4%
Ameriprise
56
Ameriprise
Minnesota
$6.61M -$2M -28,647 -27%
CC
57
Casdin Capital
New York
$6.55M
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$6.5M +$869K +12,471 +20%
Man Group
59
Man Group
United Kingdom
$6.08M -$1.72M -24,724 -26%
LCG
60
Lisanti Capital Growth
New York
$5.5M +$4.38M +62,915 New
Allianz Asset Management
61
Allianz Asset Management
Germany
$5.36M +$324K +4,649 +8%
OCM
62
Osterweis Capital Management
California
$5.32M +$314K +4,510 +8%
Voloridge Investment Management
63
Voloridge Investment Management
Florida
$5.19M +$4.14M +59,359 New
Bank of America
64
Bank of America
North Carolina
$5.12M +$230K +3,308 +6%
FLAM
65
First Light Asset Management
Minnesota
$4.79M -$9.61M -137,996 -72%
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$4.75M +$2.08M +29,844 +122%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$4.51M +$660K +9,469 +22%
SBH
68
Segall Bryant & Hamill
Illinois
$4.4M +$2.53M +36,379 +261%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$4.39M +$1.2M +17,245 +52%
Two Sigma Investments
70
Two Sigma Investments
New York
$4.37M -$2.15M -30,903 -38%
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$4.27M +$411K +5,900 +14%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$3.58M -$107K -1,540 -4%
ACH
73
ArrowMark Colorado Holdings
Colorado
$3.49M
First Trust Advisors
74
First Trust Advisors
Illinois
$3.49M +$2.78M +39,912 New
WG
75
Winton Group
United Kingdom
$3.35M +$2.67M +38,354 New

TPTX Hedge Fund Activity: Q3 2020 in Review

166 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q3 2020, worth a combined $3.45B — up 44% from $2.4B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new TPTX positions and 15 closed out — a net gain of 8 holders — while 79 added to existing stakes and 44 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $86.8M. The largest seller was Pictet Asset Management (UK), cutting an estimated $26M.

  • 166 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q3 2020, up from 158 in Q2 2020.
  • Funds reported $3.45B of Turning Point Therapeutics, Inc. Common Stock stock for Q3 2020, up 44% quarter-over-quarter.
  • 23 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q3 2020 and 15 closed out, a net change of +8 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q3 2020 was Fidelity Investments, an estimated $86.8M added.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q3 2020 was Pictet Asset Management (UK), an estimated $26M sold.

Based on aggregated 13F filings for Q3 2020.